Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Exkivity effectively inhibits the growth and spread of tumor cells by precisely ···【more】
Release date：2024-08-08Recommended：259
Capmatinib is a MET inhibitor developed by Novartis specifically for patients wi···【more】
Release date：2024-08-08Recommended：203
Exkivityis an innovative third-representative dermal growth factor receptor (EGF···【more】
Release date：2024-08-08Recommended：210
Capmatinib is an oral kinase inhibitor targeting mutations in the MET gene, prim···【more】
Release date：2024-08-08Recommended：220
Capmatinib is a targeted therapy for the treatment of non-small cell lung cancer···【more】
Release date：2024-08-08Recommended：251
Exkivity is a broad-spectrum inhibitor that broadly inhibits multiple mutant kin···【more】
Release date：2024-08-08Recommended：246
Exkivity is a new type of targeted therapy for lung cancer, which is a third rep···【more】
Release date：2024-08-08Recommended：248
Exkivity is a novel oral anti-cancer drug that acts as a small molecule tyrosine···【more】
Release date：2024-08-08Recommended：268
Capmatinib can be used to treat patients with METex14-mutated non-small cell lun···【more】
Release date：2024-08-07Recommended：235
Capmatinib is an oral MET inhibitor that received Breakthrough Therapy Designati···【more】
Release date：2024-08-07Recommended：233
Capmatinib is a targeted drug used to treat a specific type of non-small cell lu···【more】
Release date：2024-08-07Recommended：265
Capmatinib acts as a targeted therapy to stop the growth and spread of cancer ce···【more】
Release date：2024-08-07Recommended：239
